Clinical trials for rectal cancer
53 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Colon cancer
Rectal cancer
#NCT05489211
Locally Advanced
Metastatic
1
2
3 or more
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Antibody Drug Conjugates (ADC)
Centre Léon Bérard (Lyon), Institut Bergonié (Bordeaux)
AstraZeneca
Phase 2
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
#NCT06333314
Neuroendocrine tumor
MSI/dMMR
Systemic Treatment-Naive
Immunotherapy
Radiotherapy
Hôpital Henri-Mondor AP-HP (Créteil), Gustave Roussy (Villejuif), Centre Léon Bérard (Lyon), Hôpital Saint Antoine AP-HP (Paris)
UNICANCER
Phase 1 / Phase 2
Colon cancer
Rectal cancer
#NCT03093116
Metastatic
NTRK-1/2/3
ROS-1
1
2
3 or more
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Targeted therapy
Centre Antoine Lacassagne (Nice), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Gustave Roussy (Villejuif)
Turning Point Therapeutics, Inc.
Phase 1 / Phase 2
Colon cancer
Rectal cancer
#NCT03093116
Metastatic
NTRK-1/2/3
1
2
3 or more
Targeted therapy
Systemic Treatment-Naive
Centre Antoine Lacassagne (Nice), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Gustave Roussy (Villejuif)
Turning Point Therapeutics, Inc.
Phase 1 / Phase 2
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
#NCT06162221
Locally Advanced
Metastatic
KRAS G12C
Systemic Treatment-Naive
Systemic Treatment-Naive
Hôpital Foch (Suresnes), Centre François Baclesse (Caen ), IUCT Oncopôle (Toulouse), Institut Curie - Paris (Paris), Hôpital Louis Pradel (Bron ) (and 4 more...)
Revolution Medicines, Inc.
Phase 1 / Phase 2
Breast cancer
Lung cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
#NCT04104776
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M1
Urothelial carcinoma
Locally Advanced
Metastatic
ARID1A
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes) (and 2 more...)
Constellation Pharmaceutique
Phase 1 / Phase 2
Colon cancer
Rectal cancer
#NCT05706129
Locally Advanced
Metastatic
1
2
3 or more
Chemotherapy
Targeted therapy
Centre Hospitalier Universitaire de Grenoble (La Tronche), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Universitaire de Nantes (Nantes), IUCT Oncopôle (Toulouse) (and 3 more...)
Debiopharm International SA
Phase 1 / Phase 2
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
#NCT04585750
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), Centre Hospitalier Universitaire de Nîmes (Nîmes), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 4 more...)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Colon cancer
Rectal cancer
Liver and bile duct cancer
#NCT06596694
Adenocarcinoma
Hepatocellular carcinoma
Intrahepatic cholangiocarcinoma
Extrahepatic cholangiocarcinoma
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
Hôpital Beaujon (Clichy)
Merck Sharp & Dohme LLC
Phase 1 / Phase 2
Colon cancer
Rectal cancer
#NCT05592626
Locally Advanced
Metastatic
MSI/dMMR
1
2
3 or more
Systemic Treatment-Naive
Institut Curie - Paris (Paris), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux)
Marengo Therapeutics, Inc.